Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Castleman's disease]

C Larroche1, P Cacoub, P Godeau

  • 1Service de médecine interne, hôpital de la Pitié-Salpêtrière, Paris, France.

La Revue De Medecine Interne
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome and prognosis of isolated carotid vasculitis.

Journal of autoimmunity·2024
Same author

[Fibrillary glomerulonephritis].

La Revue de medecine interne·2024
Same author

Behçet's disease uveitis.

La Revue de medecine interne·2023
Same author

[Neurological involvement of sarcoidosis: current diagnostic and therapeutic strategies].

La Revue de medecine interne·2023
Same author

[Monkeypox virus infection].

La Revue de medecine interne·2022
Same author

[Cutaneous hyperpigmentation, flexion of interphalangeal joints and hallux valgus in a 42 year-old patient].

La Revue de medecine interne·2022
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Castleman's disease, a lymphoproliferative disorder, presents in localized and multicentric forms. Interleukin 6 is implicated, with the multicentric type potentially leading to aggressive outcomes and associated malignancies.

Area of Science:

  • Oncology
  • Hematology
  • Pathology

Background:

  • Castleman's disease, or angiofollicular lymph node hyperplasia, was first identified in 1956.
  • It is classified into localized and multicentric subtypes.
  • The etiology remains unknown, but interleukin 6 (IL-6) plays a crucial role.

Purpose of the Study:

  • To summarize the key aspects of Castleman's disease.
  • To highlight the diagnostic criteria and clinical heterogeneity.
  • To discuss the prognostic implications and associated conditions.

Main Methods:

  • Histologic examination is the primary diagnostic method.
  • Clinical and biological signs are evaluated for heterogeneity.
  • Literature review on the role of IL-6 and associated conditions.

Related Experiment Videos

Main Results:

  • Castleman's disease exhibits varied clinical and biological signs.
  • Histologic findings are essential for diagnosis.
  • The multicentric form is associated with a poor prognosis and can present as a prelymphoma state.

Conclusions:

  • Castleman's disease is an atypical lymphoproliferative disorder.
  • IL-6 is central to the pathogenesis of Castleman's disease.
  • Malignant lymphomas and Kaposi's sarcoma are associated with Castleman's disease, particularly the multicentric form.